Company / Shares Outstanding
Monopar Therapeutics Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
6.1M
FY2025
5-year range
3.0M / 12.9M
FY2021-FY2025
Trend
+104.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 12946573.00 to 6102560.00 over the past 2 years.
Based on SEC 10-K filings.
6102560.00 in FY2025.
Improved from 12946573.00 to 6102560.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 104.7% year-over-year.
- Peak shares outstanding was recorded in FY2023.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 19.82 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 6.1M | +104.7% |
| FY2024 | 3.0M | -77.0% |
| FY2023 | 12.9M | +39.3% |
| FY2019 | 9.3M | +0.0% |
| FY2018 | 9.3M | - |
| FY2017 | 0 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026